To ensure quality in clinical trials, what should be identified prospectively?

Boost your GCP E6 (R3) exam readiness. Improve your understanding with engaging, insightful questions. Test yourself with hints and detailed explanations. Prepare effectively!

Multiple Choice

To ensure quality in clinical trials, what should be identified prospectively?

Quality is built by planning around what could most affect data integrity and participant safety. By identifying factors critical to quality prospectively, the trial team can design appropriate controls, monitoring, and data handling from the start. This enables a risk-based approach to ensure reliable results, proper protocol adherence, accurate endpoint assessment, and robust safety reporting throughout the study. The other items don’t address quality planning: a completion date is a schedule milestone, market share goals are business objectives, and the cure rate is an outcome rather than a factor that governs how the trial is conducted to protect quality.

Quality is built by planning around what could most affect data integrity and participant safety. By identifying factors critical to quality prospectively, the trial team can design appropriate controls, monitoring, and data handling from the start. This enables a risk-based approach to ensure reliable results, proper protocol adherence, accurate endpoint assessment, and robust safety reporting throughout the study. The other items don’t address quality planning: a completion date is a schedule milestone, market share goals are business objectives, and the cure rate is an outcome rather than a factor that governs how the trial is conducted to protect quality.

More practice questions